Pascal Pfister
0000-0002-2276-5042
Novartis Pharma AG
2 papers found
Refreshing results…
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
<p>Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients</p>
Missing publications? Search for publications with a matching author name.